Physicochemical screening for chemical stabilizer of erythropoietin to prevent its aggregation

ABSTRACT Recombinant protein aggregation is a problematic issue and can provoke immunological response. The aim of this study was to analyze the stability of erythropoietin (EPO), as a therapeutic protein expressed in mammalian cells, in the presence of different chemicals and find a specific stabilizer for EPO. The effects of several chemicals, including mannitol, betaine, trehalose, taurine, linoleic acid, beta-cyclodextrin, copper sulfate, spermidine, maltose, maltodextrin, sucrose, dextran, beta-alanine, myo-inositol, and cysteine, on protein stabilization through the thermally induced aggregation of EPO were monitored. Based on the results of turbidity assay for thermal aggregation, three different patterns were observed for protein stability of active pharmaceutical ingredient of EPO, namely, accelerated, dose-dependent, and inhibitory behaviors for aggregate formation due to treatment with spermidine, mannitol, and betaine, respectively. According to circular dichroism outcomes, EPO treatment with betaine and spermidine resulted in different helical contents of the secondary structure. Dynamic light scattering experiments indicated that treating EPO with betaine resulted in less protein aggregation due to freeze and thaw stresses. Betaine was able to stabilize EPO and inhibit its aggregation, as opposed to spermidine that induced protein aggregation.

[1]  C. Partch,et al.  Analysis of Protein Stability and Ligand Interactions by Thermal Shift Assay , 2015, Current protocols in protein science.

[2]  G. Ulrich Nienhaus,et al.  Protein-Ligand Interactions: Methods and Applications , 2005 .

[3]  D. Norouzian,et al.  Investigation of purification process stresses on erythropoietin peptide mapping profile , 2015, Advanced biomedical research.

[4]  I. Macdougall,et al.  Recombinant erythropoietin in clinical practice , 2003, Postgraduate medical journal.

[5]  M. Phillips-Jones,et al.  Ligand- and drug-binding studies of membrane proteins revealed through circular dichroism spectroscopy. , 2014, Biochimica et biophysica acta.

[6]  K. Aoki,et al.  Biophysical comparability of the same protein from different manufacturers: a case study using Epoetin alfa from Epogen and Eprex. , 2006, Journal of pharmaceutical sciences.

[7]  UV difference spectroscopy of ligand binding to maltose‐binding protein , 1992, FEBS letters.

[8]  C. R. Middaugh,et al.  Stabilization of proteins by low molecular weight multi-ions. , 2002, Journal of pharmaceutical sciences.

[9]  Lisa M. Shewchuk,et al.  Crystallization of protein–ligand complexes , 2006, Acta crystallographica. Section D, Biological crystallography.

[10]  G. Winter,et al.  Protein stabilization by cyclodextrins in the liquid and dried state. , 2011, Advanced drug delivery reviews.

[11]  H. Sahl,et al.  Co-Solvents as Stabilizing Agents during Heterologous Overexpression in Escherichia coli – Application to Chlamydial Penicillin-Binding Protein 6 , 2015, PloS one.

[12]  J. Oldenburg,et al.  Efficient factor VIII affinity purification using a small synthetic ligand , 2008, Journal of thrombosis and haemostasis : JTH.

[13]  Ligand-assisted Aggregation of Proteins , 2005, Journal of Biological Chemistry.

[14]  P. Goloubinoff,et al.  Chemical Chaperones Regulate Molecular Chaperones in Vitro and in Cells under Combined Salt and Heat Stresses* , 2001, The Journal of Biological Chemistry.

[15]  I. Baskakov,et al.  The osmophobic effect: natural selection of a thermodynamic force in protein folding. , 2001, Journal of molecular biology.

[16]  J. Wine,et al.  Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation (*) , 1996, The Journal of Biological Chemistry.

[17]  Mark A. Williams,et al.  Protein-Ligand Interactions , 2013, Methods in Molecular Biology.